Travis Murdoch
CEO and President, Director · Braveheart Bio, Inc.
- 2026
- Aug 7, 2026
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Travis Murdoch files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Forbion Growth Opportunities Fund III Cooperatief U.A. - $64.80M in BRVE purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $34.92M in BRVE purchases and sales in the last 12 months
- Erez Chimovits - $34.92M in BRVE purchases and sales in the last 12 months
- AH Bio Fund IV, L.P. - $19.80M in BRVE purchases and sales in the last 12 months
- Christopher Viehbacher - $1.50M in BRVE purchases and sales in the last 12 months
- David Charles Lubner - $1000K in BRVE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Travis Murdoch?
Travis Murdoch is a corporate insider, tracked as CEO and President, Director of Braveheart Bio, Inc. (BRVE). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Travis Murdoch submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Travis Murdoch been buying or selling stock?
Recorded transactions: 1 open-market purchase ($1.50M) and 0 open-market sales across all tracked filings.
